Bellevue Life Sciences Acquisition Corp. News

10-Q: Q3 2024 Earnings Report

Nov 14 17:11 ET

SC 13G: Statement of acquisition of beneficial ownership by individuals-RIVERNORTH CAPITAL MANAGEMENT, LLC(6.07%)

Nov 14 16:53 ET

8-K: Current report

Nov 12 16:58 ET

S-4/A: Registration of securities issued in business combination transactions (Amendment)

Nov 8 22:19 ET

ARS: Annual Report to Security Holders

Oct 28 09:04 ET

DEF 14A: Definitive information statements

Oct 28 09:04 ET

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Oct 28 08:39 ET

8-K: Current report

Oct 28 08:34 ET

8-K: Current report

Oct 22 16:24 ET

PRE 14A: Preliminary proxy statements relating to merger or acquisition

Oct 18 17:34 ET

8-K: Current report

Oct 15 16:25 ET

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Oct 10 16:40 ET

8-K: Current report

Oct 10 16:36 ET

8-K: Current report

Oct 10 16:35 ET

8-K: Current report

Sep 24 16:26 ET

8-K: Current report

Sep 16 16:19 ET

8-K: Current report

Aug 22 16:25 ET

10-Q: Q2 2024 Earnings Report

Aug 19 16:23 ET

8-K: Current report

Aug 16 16:24 ET

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Aug 15 16:34 ET